Krystal Biotech, Inc.
DE ˙ DB ˙ US5011471027
257,90 € ↓ -1,10 (-0,42%)
2026-06-04
AKTIENPREIS
SecurityDE:4KB / Krystal Biotech, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership15,937 shares
Latest Disclosed Value $ 4,116,846
Creative Planning reports 14.81% increase in ownership of 4KB / Krystal Biotech, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 15,937 shares of Krystal Biotech, Inc. (DE:4KB) valued at $3,429,642 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 13,881 shares of Krystal Biotech, Inc.. This represents a change in shares of 14.81% during the quarter. The current value of the position is $4,110,152 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 15,937 2,056 14.81 4,117 20.28 0.0027
2026-02-17 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 13,881 2,272 19.57 3,422 67.01 0.0024
2025-11-14 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 11,609 3,253 38.93 2,049 78.48 0.0016
2025-08-08 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 8,356 -3,730 -30.86 1,149 -47.32 0.0010
2025-05-15 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 12,086 6,689 123.94 2,179 157.87 0.0020
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 5,397 -347 -6.04 845 -19.14 0.0008
2024-10-11 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 5,744 2,260 64.87 1,046 63.54 0.0010
2024-08-15 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 3,484 618 21.56 640 25.54 0.0007
2024-05-13 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 2,866 2,866 510 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.